Growth Hormone Disorders Completed Phase Trials for Somatotropin (DB00052)

Also known as: Growth Hormone Disorder

IndicationStatusPhase
DBCOND0036845 (Growth Hormone Disorders)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01604161Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome
NCT01580605French National Registry of Adults With Growth Hormone Deficiency Treated With Somatropin
NCT01543880Safety and Efficacy of Long-term Somatropin Treatment in Adults
NCT01543867Safety and Efficacy of Long-term Somatropin Treatment in Children
NCT01327924Usability and Tolerability of the Norditropin NordiFlex® Injection Device in Children Never Previously Treated With Growth Hormone
NCT01109017Observational Study of the Safety and Efficacy of Norditropin® in Adult Patients With Growth Hormone Deficiency
NCT01009905An Observational Study (Registry) Assessing Treatment Outcomes and Safety for Children and Adults Who Are Prescribed Norditropin® (Human Growth Hormone)
NCT00960128Observational Prospective Study on Patients Treated With Norditropin®
NCT00934063An Observational Study Validating a Score That Quantifies the Therapeutic Response to Treatment With Norditropin®